A review of disease burden and clinical management for generalized pustular psoriasis in China

J Lu, Y Shi - Expert Review of Clinical Immunology, 2022 - Taylor & Francis
Introduction Generalized pustular psoriasis (GPP) is a rare, severe, immune-mediated and
potentially life-threatening skin disease. The rarity, differential diagnoses, relapsing nature …

An update on generalized pustular psoriasis

MJ Gooderham, AS Van Voorhees… - Expert review of clinical …, 2019 - Taylor & Francis
Introduction: Generalized pustular psoriasis (GPP) is a rare, severe relapsing/remitting,
multisystem disease that can be difficult to treat. Recent clinical, histological, and genetic …

Generalized pustular psoriasis: current management status and unmet medical needs in Japan

M Komine, A Morita - Expert Review of Clinical Immunology, 2021 - Taylor & Francis
Introduction Generalized pustular psoriasis (GPP) is a rare, inflammatory skin disease
characterized by recurrent flares of pustulation accompanied by systemic symptoms that can …

[HTML][HTML] Treatment options and goals for patients with generalized pustular psoriasis

J Krueger, L Puig, D Thaçi - American Journal of Clinical Dermatology, 2022 - Springer
Generalized pustular psoriasis (GPP) is a rare, severe neutrophilic skin disorder
characterized by sudden widespread eruption of superficial sterile pustules with or without …

[HTML][HTML] Generalized pustular psoriasis: a review on clinical characteristics, diagnosis, and treatment

R Rivera-Díaz, E Daudén, JM Carrascosa… - Dermatology and …, 2023 - Springer
Generalized pustular psoriasis (GPP) is a rare, chronic, and severe inflammatory skin
disorder characterized by sudden eruption of sterile pustules, often accompanied by …

Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis

AD Burden - Expert Review of Clinical Immunology, 2023 - Taylor & Francis
Introduction Generalized pustular psoriasis (GPP) is a rare cutaneous and systemic
inflammatory disease which is characterized by flares of widespread painful pustulation of …

IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis

A Johnston, X Xing, L Wolterink, DH Barnes… - Journal of Allergy and …, 2017 - Elsevier
Background Generalized pustular psoriasis (GPP) is a rare, debilitating, and often life-
threatening inflammatory disease characterized by episodic infiltration of neutrophils into the …

[HTML][HTML] Commentary: unmet needs in generalized pustular psoriasis in clinical practice

A Balato, F Ambrogio, M Burlando, CG Carrera… - Dermatology and …, 2024 - Springer
Generalized pustular psoriasis (GPP) is a rare and chronic inflammatory skin disease
characterized by recurrent flares of pustulation with or without systemic inflammation that …

[HTML][HTML] Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence

T Bhutani, AS Farberg - Dermatology and Therapy, 2024 - Springer
Generalized pustular psoriasis (GPP) is a chronic, rare, and potentially life-threatening
disease. There is limited understanding of patient characteristics in GPP and their …

Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors

CO Maçães, AM Lé, T Torres - Journal of Dermatological Treatment, 2022 - Taylor & Francis
Generalized pustular psoriasis (GPP) is a rare yet severe variant of psoriasis, characterized
by the eruption of superficial sterile pustules that appear suddenly and widely distributed …